Prevalence of Hidradenitis Suppurativa in an African population: Validation of a screening questionnaire in Lagos, Nigeria

Letter Dermatology

Prevalence and perceptions towards hidradenitis suppurativa: a cross-sectional study in a non-dermatological outpatient population

H. R. Han et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)

Add to Collection

Letter Dermatology

Prevalence of Hidradenitis Suppurativa in Berekum, Ghana

Paa Gyasi Hagan et al.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Add to Collection

Article Dermatology

Activity and components of the granulocyte colony-stimulating factor pathway in hidradenitis suppurativa

K. Wolk et al.

Summary: The expression of G-CSF is high in HS skin, especially in inflamed nodules and abscesses. IL-1 and IL-17 induce G-CSF production, and G-CSF blood levels correlate with the severity of HS.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Review Dermatology

Hidradenitis suppurativa: pathogenesis, clinical presentation, epidemiology, and comorbid associations

Ana Preda-Naumescu et al.

Summary: Hidradenitis suppurativa is a chronic inflammatory skin condition with a range of symptoms, from painful nodules to abscesses, associated with various mechanisms and comorbidities. It significantly impairs patients' quality of life and requires early recognition and treatment.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2021)

Add to Collection

Article Dermatology

Hidradenitis suppurativa in South-East Asia and East Asia

Christos C. Zouboulis et al.

Summary: Hidradenitis suppurativa in South-East Asia and East Asia exhibits distinct clinical, environmental, physiological, and likely genetic differences compared to the Western region, with a male predominance, varying affected areas, and common metabolic comorbidities. Further studies on Asian ethnic subgroups are warranted.

EXPERIMENTAL DERMATOLOGY (2021)

Add to Collection

Review Dermatology

Prevalence of Hidradenitis Suppurativa A Systematic Review and Meta-regression Analysis

Abdulhadi Jfri et al.

Summary: The prevalence of hidradenitis suppurativa (HS) was estimated to be 0.40% in the overall population, with clinical samples showing a higher prevalence (1.7%) compared to population-based studies (0.3%). These findings can aid in policy formulation and guiding principles for better disease diagnosis.

JAMA DERMATOLOGY (2021)

Add to Collection

Review Dermatology